menu
    • menu

    Company profile for AngioDynamics

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AngioDynamics is a leading medical technology company focused on restoring healthy blood flow, expanding cancer treatment options, and improving patient quality of life. Its innovative devices are trusted by skilled physicians to address unmet needs in fast-growing healthcare markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AngioDynamicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    603 Queensbury Avenue, Queensbury, NY 12804
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.angiodynamics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/angiodynamics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/angiodynamics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AngioDynamics Reports Fiscal Year 2026 Q3 Financial Results
    AngioDynamics Reports Fiscal Year 2026 Q3 Financial Results

    02 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260402702603/en/AngioDynamics-Reports-Fiscal-Year-2026-Third-Quarter-Financial-Results-Sustained-Double-Digit-Med-Tech-Growth-Drives-Continued-Profitability

    BUSINESSWIRE
    02 Apr 2026
    Share Share
    AngioDynamics to Report Fiscal 2026 Q3 Results on April 2, 2026
    AngioDynamics to Report Fiscal 2026 Q3 Results on April 2, 2026

    19 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260319467140/en/AngioDynamics-to-Report-Fiscal-2026-Third-Quarter-Results-on-April-2-2026

    BUSINESSWIRE
    19 Mar 2026
    Share Share
    Angiodynamics Presents At Leerink Partners Healthcare Conf
    Angiodynamics Presents At Leerink Partners Healthcare Conf

    23 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260223962165/en/AngioDynamics-to-Present-at-the-Leerink-Partners-Global-Healthcare-Conference

    BUSINESSWIRE
    23 Feb 2026
    Share Share
    Angiodynamics Broadens Nanoknife System Indications In Europe
    Angiodynamics Broadens Nanoknife System Indications In Europe

    19 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260219441352/en/AngioDynamics-Expands-Indications-for-the-NanoKnife-System-Across-Europe-Strengthening-Multi-Organ-Tumor-Ablation-Platform

    BUSINESSWIRE
    19 Feb 2026
    Share Share
    AngioDynamics, PERT Launch Pulmonary Embolism Fund
    AngioDynamics, PERT Launch Pulmonary Embolism Fund

    05 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260205480931/en/AngioDynamics-and-The-PERT-Consortium-Launch-Investigator-Led-Research-Fund-to-Advance-Pulmonary-Embolism-Care

    BUSINESSWIRE
    05 Feb 2026
    Share Share
    AngioDynamics Hosts Forum on Pipeline Advances
    AngioDynamics Hosts Forum on Pipeline Advances

    03 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260203906950/en/AngioDynamics-to-Convene-Cardiovascular-Leaders-at-Scientific-Forum-as-Pipeline-Continues-to-Advance

    BUSINESSWIRE
    03 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search